A Systematic Review of Immune Cell Roles in Breast Cancer Immunotherapy
Cancer Reports · 2025-05 · 8 (5)
DOI: 10.1002/cnr2.70217 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Cancer Reports, online erschienen am 12.05.2025. Verfasst von Rui Li und 3 weiteren Autor:innen. Beteiligte Einrichtung: Shandong Provincial Hospital, Affiliated to Shandong First Medical University, Jinan, Shandong, China. Hauptthemen laut MEDLINE: Breast Neoplasms, Tumor Microenvironment, Immunotherapy. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science and Technology Innovation Program of Xiong'an New Area, National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
Breast cancer (BC) is the most prevalent malignancy among women and is associated with high mortality and significant clinical challenges. Although conventional treatments such as surgery, chemotherapy, and radiotherapy have significantly improved patient survival, their efficacy remains limited by severe side effects and treatment resistance. In recent years, advances in immunotherapy have underscored the pivotal role of immune cells in treating BC. Recent Findings This systematic review summarizes the current knowledge on the roles of immune cells within the BC tumor microenvironment (TME), including their phenotypes, functions, and implications for immunotherapy. Following PRISMA guidelines, 71 studies published between 2010 and 2024 were analyzed. The results indicate that immune cell populations—such as tumor‐associated macrophages (TAMs), tumor‐infiltrating lymphocytes (TILs), natural killer (NK) cells, dendritic cells (DCs), and myeloid‐derived suppressor cells (MDSCs)—are integral to tumor progression and therapeutic response. However, their functional heterogeneity and plasticity remain key obstacles to the development of effective and personalized immunotherapeutic strategies.
Conclusion
Further research is needed to clarify the mechanisms governing immune cell behavior within the BC TME and to advance precision immunotherapy. Such insights will lay the foundation for individualized treatment approaches, ultimately improving patient outcomes and quality of life (QoL).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Shandong Provincial Hospital, Affiliated to Shandong First Medical University, Jinan, Shandong, China.
- Department of General Surgery, Shandong Provincial Hospital, Jinan, Shandong, China.
- Urology, Shandong University, Jinan, Shandong, China.
- Department of Internal Medicine, Shandong Provincial Hospital, Jinan, Shandong, China.
ORCID-Profile: Rui Li
Förderung
- Science and Technology Innovation Program of Xiong'an New Area
- National Natural Science Foundation of China
Zitieren
APA
Li, R., Lv, W., Wang, D. L., & Chen, N. (2025). A Systematic Review of Immune Cell Roles in Breast Cancer Immunotherapy. Cancer Reports, 8(5). https://doi.org/10.1002/cnr2.70217
Vancouver
Li R, Lv W, Wang DL, Chen N. A Systematic Review of Immune Cell Roles in Breast Cancer Immunotherapy. Cancer Reports. 2025;8(5). doi:10.1002/cnr2.70217
BibTeX
@article{Li2025,
author = {Li, Rui and Lv, Wei and Wang, Dong Liang and Chen, Na},
title = {A Systematic Review of Immune Cell Roles in Breast Cancer Immunotherapy},
journal = {Cancer Reports},
year = {2025},
volume = {8},
number = {5},
doi = {10.1002/cnr2.70217}
}
EUVIMED